期刊文献+

阿法骨化醇治疗老年性骨质疏松症的疗效和预防分析 被引量:12

Therapeutic Effect of Alfacalcidol on Senile Osteoporosis and Analysis of Its Preventive Measures
原文传递
导出
摘要 目的探讨阿法骨化醇治疗老年性骨质疏松症的疗效和预防措施。方法 100例老年原发性骨质疏松症患者根据入院顺序平分为两组-治疗组与对照组各50例,对照组患者每天口服钙剂治疗,治疗组在此基础上加用阿法骨化醇片治疗。结果两组治疗前的股骨颈、L 2-4骨密度比较差异无统计学意义(P>0.05)。治疗后,两组指标都有明显增加,但是治疗组患者股骨颈、L 2-4骨密度较对照组均明显增加,差异有统计学意义(P<0.05)。经过治疗后,治疗组的疼痛改善总有效率为80.0%,对照组的疼痛改善总有效率为40.0%,治疗组明显好于对照组(P<0.05)。结论阿法骨化醇治疗老年性骨质疏松症能够有效提高股骨颈、L 2-4骨密度,缓解疼痛症状,但是在治疗中注重预防措施。 Objective To explore the therapeutic efficacy of alfacalcidol on senile osteoporosis and to discuss its preventive measures.Methods One hundred elderly patients with primary osteoporosis were divided into two groups(each n=50).The control group was treated with basic daily oral calcium,while the treatment group was added alfacalcidol therapy based on the basic treatment.Results Before the treatment,no statistically significant difference was found in the femoral neck and L 2-4 BMD between the two groups(P0.05).After the treatment,the indicators of the two groups were increased significantly,but the femoral neck and L 2-4 BMD in the treatment group were significantly higher than those in the control group(P0.05).After the treatment,the total response rate of pain improvement was 80.0% in the treatment group and 40.0% in the control group,the treatment group was superior to the control group(P0.05).Conclusions Alfacalcidol treatment of senile osteoporosis can effectively improve the femoral neck and L 2-4 bone mineral density and relieve the pain,but more attention should be paid to the preventive measures in the treatment course.
作者 王顺义
出处 《实用预防医学》 CAS 2011年第8期1519-1520,共2页 Practical Preventive Medicine
关键词 阿法骨化醇 老年骨质疏松症 骨密度 疼痛 Alfacalcidol Senile osteoporosis Bone mineral density Pain
  • 相关文献

参考文献7

二级参考文献46

  • 1中国人原发性骨质疏松症诊断标准(试行)[J].中国骨质疏松杂志,1999,5(F03):1-3. 被引量:325
  • 2朱汉民,王赞舜.老年人骨折的流行病学及其对生命质量的影响[J].中华老年医学杂志,1993,12(3):168-172. 被引量:41
  • 3杨素敏,黄媛霞,刘亚飞.阿法骨化醇胶丸配合中药外敷治疗胫骨结节骨软骨炎[J].中医正骨,2005,17(9):17-17. 被引量:4
  • 4Physician's guide to prevention and treatment Of osteoporosis. Excerpt Medical, Inc. Bell Mead, 1999 New Jersey. National Osteoporosis Foundation.
  • 5Lau E M. Epidemiology of "osteopomsis in urbanized Asia population Osteopomsis Int, 1997,7 (Suppl) : S91 - 95.
  • 6Avioli LV. Epidemiology of osteopomsis and its complications. In:Peck WA, eds. Prevention of postmenopausal osteoporosis. Casterton Hall, Carnfirth, Lanes, LA6 2LA, UK. The Parthenon Publishing Group Ktd ,1990, 12 - 13.
  • 7Lips P. Epidemiology and predictors of fractures associated with osteopomsis. Am J Med,103(2A) :3S - 11S.
  • 8Melton LJ Ⅲ , Themer M, Ray NF, et al. Fracture attributable to osteoporosis: report from the National Osteoporosis Foundation.JBMR, 1997, 12 : 16 - 23.
  • 9Orimo H, Shiraki M, Hayashi Y, et al. Effects of 1 alpha-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patient with postmenopausal osteoporosis[J]. Cacif Tissue Int, 1994,54(5):370-376.
  • 10Francis R M, Boyle I T, Moniz C, et al. A comparison of the effects of alfacalcidol treatment and vitamin D3 supplementation on calcium absorption in ederly women with vertebral fracture[J]. Osteoporosis Int, 1996,6(4):284-290.

共引文献80

同被引文献58

  • 1李平生.老年人骨质疏松症[J].人民军医,2004,47(7):419-421. 被引量:28
  • 2王文健.肾主骨理论与中西医结合治疗骨质疏松症的研究[J].中国骨质疏松杂志,1998,4(1):42-44. 被引量:75
  • 3谢新荣,罗佐杰,秦映芬,梁杏欢,张英.利塞膦酸钠对绝经后骨质疏松症的疗效与安全性研究[J].中国现代医学杂志,2007,17(14):1729-1732. 被引量:6
  • 4毛杰.综合疗法治疗老年性骨质疏松症的效果观察[J].2011,9(8):107.
  • 5Consensus development conference. Diagnosis,prophylaxis,and the treatment of ostcoporosis[J].American Journal of Medicine,1993,(06):646-650.
  • 6BARON R. Osteoporosis in 201 1:Osteoporosis therapy-dawn of the post-bisphosphonate era[J].Nature Reviews Endocrinology,2011.76-78.
  • 7SIDDIQI A,PAYNE AG,ZAFAR S. Bisphosphonate induced ostconecrosis of the jaw:a medical enigma[J].Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology & Endodontics,2009.e1-e8.
  • 8CRANNEY A,WELLS G,WILLAN A,GRIFFITH L,Zytaruk N,Robinson V,Black D,Adachi J,Shea B,Tugwell P,Guyatt G. Ⅱ.Meta-analysis of alendronate for the treatment of postmenopausal women[J].ENDOCRINE REVIEWS,2002.508-516.
  • 9Inan Anaforoglu,Asli Nar-Demirer,Neslihan Bascil-Tutuncu,Melek Eda Ertorer.Prevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetes[J].Journal of Diabetes and Its Complications.2009(1)
  • 10娄志杰,韩向莉,孙勤,赵建美.骨质疏松症中医证型实质的研究思路[J].时珍国医国药,2007,18(12):3093-3094. 被引量:12

引证文献12

二级引证文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部